Disease free survival of TNBC stratified by AR and EGFR.

Abstract

<p>Cases were stratified into three risk groups: 1. Low risk: AR+ EGFR-; 2. Intermediate risk: AR+ EGFR+ or AR- EGFR-; 3. High Risk: AR- EGFR+.</p